CXCL8 and neutropenia: Our research presents compelling evidence that assessing cytokine concentrations, specifically IL-8 and VEGF, can be useful in predicting hematological complications such as lymphopenia, neutropenia, anemia, infection, and polyneuropathy in MM patients.